Eva Domingo-Domenech

22PUBLICATIONS
134CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)NanomedicinePersonality and individual differencesMolecular targetsInfectious diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|Aug 27, 2026
Radiation-Free Therapy for the Initial Treatment of Good Prognosis Early Non-Bulky Hodgkin Lymphoma, Defined by a Low Metabolic Tumor Volume and a Negative Interim PET After 2 Chemotherapy Cycles: The RAFTING Trial Protocol.

|Aug 25, 2026
Real-world effectiveness and safety of Zanubrutinib in Spanish patients with relapsed/refractory marginal zone lymphoma.

|May 05, 2026
Sarcopenia in Patients With Cancer and Its Association With Chemotherapy-Induced Peripheral Neurotoxicity.

|Dec 29, 2025
Brentuximab vedotin and nivolumab in combination with chemotherapy for nonbulky, early-stage classical Hodgkin lymphoma.

Jeremy S Abramson, David J Straus, Nancy L Bartlett

|Nov 26, 2025
Asparaginase Hypersensitivity Reactions in NK/T-Cell Lymphomas.

Javier Varela Gonzalez-Aller, Pablo Nadal, Salome Cañizares

|Aug 19, 2025
Association of PET4 response with outcomes of BV-CHP vs CHOP in the ECHELON-2 trial in CD30+ peripheral T-cell lymphoma.

Swaminathan Iyer, Neha Mehta-Shah, Ranjana Advani

Pageof 4

Frequent Collaborators

6 joint publications

Pier Luigi Zinzani

4 joint publications

Anna Sureda

3 joint publications

Kerry J Savage

3 joint publications

Marek Trneny